SHL Telemedicine director reports initial holdings

SHL Telemedicine director Yehoshua Abramovich reported his initial ownership in the company.

Accepted by SEC EDGAR 03/25/2026 - 09:16 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SHL Telemedicine director Yehoshua Abramovich reported his initial ownership in the company. He directly holds 46,109 Ordinary Shares and a series of stock options with an exercise price of CHF 17.02 per share, expiring on December 9, 2027, covering a total of 18,000 underlying Ordinary Shares vesting in multiple 1,500-share tranches.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Abramovich Yehoshua

Role Director

Type	Security	Shares	Price	Value
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Option	--	--	--
Holding	Ordinary Shares	--	--	--

Holdings: Option — 18,000 contracts (Direct); Ordinary Shares — 46,109 shares (Direct)

Footnotes (1)

1. F1. The exercise price is in CHF.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SHL Telemedicine (SHMLF) report in Yehoshua Abramovich’s Form 3?

SHL Telemedicine reported director Yehoshua Abramovich’s initial ownership. He holds 46,109 Ordinary Shares directly plus options on additional shares, giving investors a clear view of his current equity stake in the company.

How many SHL Telemedicine (SHMLF) Ordinary Shares does Yehoshua Abramovich own directly?

The filing shows Abramovich directly owns 46,109 Ordinary Shares of SHL Telemedicine. This figure represents his reported common share position and excludes shares that may be acquired through stock options in the future.

What stock options were disclosed for Yehoshua Abramovich in SHL Telemedicine (SHMLF)?

Abramovich holds options over 18,000 underlying Ordinary Shares at an exercise price of CHF 17.02. These options vest in several tranches between December 2022 and December 2024 and expire on December 9, 2027.

What is the exercise price and currency of Abramovich’s SHL Telemedicine (SHMLF) options?

The options granted to Abramovich carry an exercise price of CHF 17.02 per Ordinary Share. A footnote clarifies that the exercise price is denominated in Swiss francs, not in U.S. dollars or another currency.

When do Yehoshua Abramovich’s SHL Telemedicine (SHMLF) options expire?

All reported option grants to Abramovich share an expiration date of December 9, 2027. After this date, any unexercised options would lapse, meaning they could no longer be used to purchase SHL Telemedicine Ordinary Shares.

Does Yehoshua Abramovich’s Form 3 for SHL Telemedicine (SHMLF) show recent share purchases or sales?

The Form 3 lists holdings only and shows no recorded buy or sell transactions. Entries are classified as holdings with unknown transaction codes, indicating a snapshot of existing ownership rather than new trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abramovich Yehoshua

(Last) (First) (Middle)

HAKNESET 49

(Street)

GIVATAIM 5346515

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SHL TELEMEDICINE LTD [ SHLT ]

3a. Foreign Trading Symbol
[SHLTN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	46,109	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option	12/08/2022	12/09/2027	Ordinary Shares	6,000	$17.02(1)	D
Option	03/08/2023	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	06/08/2023	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	09/08/2023	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	12/08/2023	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	03/08/2024	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	06/08/2024	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	09/08/2024	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D
Option	12/08/2024	12/09/2027	Ordinary Shares	1,500	$17.02(1)	D

Explanation of Responses:

1. The exercise price is in CHF.

Remarks:

This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.

	/s/ Abramovich Yehushua	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)